Fairooz Kabbinavar
CIK 1774182 · Chief Medical Officer · last filed 2025-03-13
Fairooz Kabbinavar is a Chief Medical Officer who has filed 4 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for CRDF, was dated Mar 13, 2025.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
4
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRDF | Chief Medical Officer | — | $1.54 | — | $0 | 2 | 2025-03-13 |
| Forte Biosciences, Inc. (TOCA) Delisted | SVP Clinical Development | — | — | — | $0 | 2 | 2019-10-04 |
Recent Filings
4 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-13 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2024-03-07 | CRDF | Grant (A) | — | $0 | EDGAR |
| 2019-10-04 | Forte Biosciences, Inc. (TOCA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-04-17 | Forte Biosciences, Inc. (TOCA) Delisted | Grant (A) | — | $0 | EDGAR |